Live Webinar

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Hosted by AJMC, Managed Healthcare Executive, Pharmacy Times and PBMI

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
|Articles|October 1, 1996

The American Journal of Managed Care

  • October 1996
  • Volume 2
  • Issue 9

Estimating Prevalence and Detection Cost: Prerequisites for Disease State Management of Attention Deficit Hyperactivity Disorder

Download PDF: Estimating Prevalence and Detection Cost: Prerequisites for Disease State Management of Attention Deficit Hyperactivity Disorder

Articles in this issue

almost 30 years ago

Use of a New Antiepileptic Drug in an HMO: Economic Outcomes from the Payer Perspective

almost 30 years ago

The Influence of New Devices on the Costs of Interventional Procedures

almost 30 years ago

Patterns of Antidepressant Use and Their Relation to Costs of Care

almost 30 years ago

Comparison of a Decision Analytic Model with Results from a Naturalistic Economic Clinical Trial: An Application to Evaluating Alternative Antidepressants

almost 30 years ago

Comparison of a New Hand-Held Interactive Airway Monitoring System and a Conventional Peak Expiratory Flow Meter in the Management of Asthma

almost 30 years ago

The Psychopharmacology of Depression in the Managed Care Setting

almost 30 years ago

Cost-Effective Treatment of Depression

almost 30 years ago

Correspondence regarding, "HEDIS 3.0: Advancing the State of the Art in Health Plan Performance Measurement"

Related Content